13,603 Followers on Owler

Vicore Pharma

Read more
Carl-Johan Dalsgaard's photo - CEO of Vicore Pharma

CEO

Carl-Johan Dalsgaard

CEO Approval Rating

93/100

Founded:

2000

Status:

PublicIndependent CompanyNasdaq OMX NordicVICO

VICORE PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Vicore Pharma's company profile
Carl-Johan Dalsgaard's photo - CEO of Vicore Pharma

Carl-Johan Dalsgaard

CEO

93/100
13
$20M
$ < 1M
View Profile
1
Vicore Pharma's Competitor - Gesynta logo
Patric Stenberg's photo - Co-Founder & CEO of Gesynta

Patric Stenberg

Co-Founder & CEO

87/100
12
$30M
$1.2M
View Profile
2
Vicore Pharma's Competitor - Attgeno  logo
Per Agvald's photo - CEO of Attgeno

Per Agvald

CEO

88/100
14
$3.8M
$1.3M
View Profile
3
Vicore Pharma's Competitor - Cardurion logo
Peter S. Lawrence's photo - President & CEO of Cardurion

Peter S. Lawrence

President & CEO

88/100
56
$25.6M
$4M
View Profile
4
Vicore Pharma's Competitor - Ubiquiti logo
Robert J. Pera's photo - Chairman & CEO of Ubiquiti

Robert J. Pera

Chairman & CEO

58/100
843
$105.6M
$1.9B
View Profile
5
Vicore Pharma's Competitor - Eli Lilly logo
David A. Ricks's photo - Chairman & CEO of Eli Lilly

David A. Ricks

Chairman & CEO

65/100
38,680
- -
$26.7B
View Profile

Missing a competitor? Contribute!

Gesynta is seen as one of Vicore Pharma's top competitors. Gesynta's headquarters is in Solna, Stockholms län, and was founded in 2017. Like Vicore Pharma, Gesynta also works within the Biotechnology industry. Gesynta generates 236% of Vicore Pharma's revenue.

Attgeno is one of Vicore Pharma's top rivals. Attgeno was founded in 2005, and its headquarters is in Solna, Stockholms län. Like Vicore Pharma, Attgeno also works within the Biotechnology field. Attgeno has 1 more employees than Vicore Pharma.

Cardurion is Vicore Pharma's #3 rival. Cardurion is a Private company that was founded in 2017 in Boston, Massachusetts. Like Vicore Pharma, Cardurion also competes in the Biotechnology sector. Compared to Vicore Pharma, Cardurion has 43 more employees.

Vicore Pharma Quarterly and Annual Revenue

Coming soon for Vicore Pharma!

Annual Revenue

$ < 1M

Vicore Pharma's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 4.8B.

Vicore Pharma Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

INIM Pharma AB

Jul 2018

Source »
undisclosed
-

These are all the companies that Vicore Pharma has acquired. Vicore Pharma's latest acquisition was INIM Pharma AB in Jul 2018.

Vicore Pharma Funding History

Since Vicore Pharma was founded in 2000, it has participated in 2 rounds of funding. In total Vicore Pharma has raised $20.0M. Vicore Pharma's last funding round was on Jul 2020 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jul 2020
$20M
-
IPO
Sep 2019
--
-

Since Vicore Pharma was founded in 2000, it has participated in 2 rounds of funding. In total Vicore Pharma has raised $20.0M. Vicore Pharma's last funding round was on Jul 2020 for a total of $20.0M

Vicore Pharma Investments

No recent investments found related to Vicore Pharma

Vicore Pharma News

June 11, 2021Markets Insider

Vicore announces FDA acceptance for pivotal phase 3 trial of C21 in COVID-19

GOTHENBURG, Sweden, June 11, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ('Vicore'), a rare ... See more »
May 5, 2021BioSpace

Vicore Pharma Holding AB

In February, Vicore completed a directed share issue raising 336 MSEK. The share issue was approved a... See more »
May 5, 2021NS Medical Devices

Vicore, Alex Therapeutics partner to develop new digital therapeutic for IPF

The post Vicore, Alex Therapeutics partner to develop new digital therapeutic for IPF appeared first ... See more »
April 20, 2021Markets Insider

Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19

KOL webinar being held on Wednesday, April 28th @ 14:00 CET (8 am EST)GOTHENBURG, Sweden, April 20, 2... See more »
April 15, 2021BioSpace

Vicore Pharma publishes the Annual Report for 2020

Vicore Pharma Holding AB, a pharmaceutical company developing innovative medicines for severe lung di... See more »
March 17, 2021MarketScreener

drug candidate C21 dilates peripheral resistance vessels in fibrotic disease

(marketscreener.com) 2021-03-11 Gothenburg, March 11, 2021 - Vicore Pharma Holding AB , a pharmaceuti... See more »
March 11, 2021Markets Insider

Vicore Pharma's drug candidate C21 dilates peripheral resistance vessels in fibrotic disease

GOTHENBURG, Sweden, March 11, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ), a pharmaceutical ... See more »

Vicore Pharma Press Releases

February 9, 2021Cision

Notice of extraordinary general meeting of Vicore Pharma Holding AB (publ)

The shareholders of Vicore Pharma Holding AB (publ), Reg. No. 556680-3804, with registered office... See more »
November 3, 2020Cision

Vicore announces changes in management team

Gothenburg, November 3, 2020 - Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated... See more »
October 1, 2020Cision

Vicore Pharma announces completion of patient enrollment in the COVID-19 ATTRACT trial

Gothenburg, October 1, 2020 - Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated... See more »
August 31, 2020Cision

Increase of number of shares and votes in Vicore Pharma

Gothenburg, August 31, 2020 - Vicore Pharma Holding AB (publ)'s ("Vicore Pharma", or the "Company")... See more »

Social Media

Vicore Pharma Headquarters

Kronhusgatan 11

Gothenburg, Västra Götalands län411 05

46-31-788-05-60

Driving Directions »

Trending Companies

Vicore Pharma Summary

ABOUT

Overview

Vicore Pharma is a biotechnology company that develops and commercializes drugs for the treatment of fibrotic lung diseases. Vicore Pharma was founded in 2000. Vicore Pharma's headquarters is located in Gothenburg, Västra Götalands län, SE 411 05. It ...

CEO

Vicore Pharma's CEO, Carl-Johan Dalsgaard, currently has an approval rating of 93%. Vicore Pharma's primary competitors are Gesynta, Attgeno & Cardurion.

Frequently Asked Questions about Vicore Pharma

  1. When was Vicore Pharma founded?

    Vicore Pharma was founded in 2000
  2. Who is Vicore Pharma's CEO?

    Vicore Pharma's CEO is Carl-Johan Dalsgaard
  3. How much revenue does Vicore Pharma generate?

    Vicore Pharma generates $ < 1M in revenue
  4. How much funding does Vicore Pharma have?

    Vicore Pharma has historically raised $20M in funding
  1. Where is Vicore Pharma's headquarters?

    Vicore Pharma's headquarters is in Gothenburg Västra Götalands län, SE
  2. How many employees does Vicore Pharma have?

    Vicore Pharma has 13 employees
  3. What sector does Vicore Pharma operate in?

    Vicore Pharma is in Pharmaceuticals, Biotechnology
  4. Who are Vicore Pharma's competitors?

    Vicore Pharma's top competitors are Gesynta, Attgeno , Cardurion